Surveillance for Chlamydia trachomatis variants escaping detection with the Aptima Combo 2 assay in Canada from 2019 to 2021
Authors:
- Felicia RoyFRFelicia Roy
- Jason J. LeBlancJLJason J. LeBlanc
- Alberto SeveriniASAlberto Severini
- On behalf of the Canadian Public Health Laboratory Network (CPHLN) Chlamydia Variant Working GroupOGOn behalf of the Canadian Public Health Laboratory Network (CPHLN) Chlamydia Variant Working Group
Open Access
- 4 March 2025
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (3) , e0206224
Abstract
Nucleic acid amplification tests (NAATs) are the method of choice for Chlamydia trachomatis diagnosis, but these strategies are susceptible to target site mutations. C. trachomatis variants escaping detection with the Aptima Combo 2 (AC2) assay on the Hologic Panther instrument from 23S rRNA mutations have been reported in Nordic countries, England, Japan, and the United States. Given the potential for false negative results, this study investigated whether strains of C. trachomatis with AC2 target site mutations were present in Canada. Surveillance was conducted in Canadian laboratories from 2019 to 2021. Specimens suspected of AC2 target site mutations included those with low-value detections on the AC2 assay, with subsequent high-value detections on the Aptima Chlamydia Trachomatis (ACT) assay used for confirmatory testing. Specimens with AC2/ACT discrepant results were subjected to sequencing of the AC2 target (i.e., 23S rRNA). Sequencing revealed 15 (4.8%) diagnostic escape variants which were carrying either C1514T, G1523A, or G1526A mutations. All specimens with a diagnostic escape mutation were detected with a reformulated version of the AC2 assay. Overall, while the prevalence of C. trachomatis variants was rare, their presence in the Canadian population supports the use of the new AC2 kit formulation and the need for ongoing genetic surveillance for NAAT-based assays. IMPORTANCE: Molecular tests are commonly used for the detection of sexually transmitted infections (STIs) like Chlamydia trachomatis . Mutations impacting C. trachomatis molecular target detection on the Hologic Panther AC2 assay have been reported in several countries, raising concerns about potential false negative results. This study showed C. trachomatis target detection failures in specimens submitted for C. trachomatis testing in Canadian laboratories from 2019 to 2021. A reformulated version of the AC2 molecular test is now available that can identify C. trachomatis strains harboring target site mutations that were impacted by the previous test formulation. While target site mutations were rare in Canada, revealing their presence is important to ensure accurate molecular detection of C. trachomatis with existing testing methods. This study supports ongoing genetic monitoring of C. trachomatis molecular test target sites, as well as the use of the reformulated test to avoid false negative results and subsequent transmissions.Keywords
This publication has 24 references indexed in Scilit:
- Chlamydia trachomatis Variants Escaping Detection in the Aptima Combo 2 Assay in the United StatesSexually Transmitted Diseases, 2022
- Reliable detection of SARS-CoV-2 with patient-collected swabs and saline gargles: A three-headed comparison on multiple molecular platformsJournal of Virological Methods, 2021
- Real-time PCR-based SARS-CoV-2 detection in Canadian laboratoriesJournal of Clinical Virology, 2020
- A Chlamydia trachomatis 23S rRNA G1523A variant escaping detection in the Aptima Combo 2 assay (Hologic) was widespread across Denmark in July–September 2019APMIS, 2020
- False-negative Chlamydia polymerase chain reaction result caused by a cryptic plasmid-deficient Chlamydia trachomatis strain in AustraliaSexual Health, 2019
- MEGA X: Molecular Evolutionary Genetics Analysis across Computing PlatformsMolecular Biology and Evolution, 2018
- Comparison of monoplex and duplex RT-PCR assays for the detection of measles virusJournal of Virological Methods, 2017
- Comparison of Workflow, Maintenance, and Consumables in the GeneXpert Infinity 80 and Panther Instruments While Testing for Chlamydia trachomatis and Neisseria gonorrhoeaeSexually Transmitted Diseases, 2016
- Detection of Influenza H7N9 Virus: All Molecular Tests Are Not EqualJournal of Clinical Microbiology, 2013
- The Swedish new variant of Chlamydia trachomatisCurrent Opinion in Infectious Diseases, 2011